Bradykinin and the pathogenesis of hereditary angioedema.

Bradykinin and the pathogenesis of hereditary angioedema.

Item
http://www.wikidata.org/entity/Q40621981
Management of urticaria: not too complicated, not too simpleComplement System Part I - Molecular Mechanisms of Activation and Regulation.An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiencyInternational consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.Icatibant as acute treatment for hereditary angioedema in adults.Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.Swedish children with hereditary angioedema report good overall health and quality of life despite symptoms.Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors.F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema.
P2860

Bradykinin and the pathogenesis of hereditary angioedema.

Item
http://www.wikidata.org/entity/Q40621981
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bradykinin and the pathogenesis of hereditary angioedema.
@en
type
label
Bradykinin and the pathogenesis of hereditary angioedema.
@en
prefLabel
Bradykinin and the pathogenesis of hereditary angioedema.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Bradykinin and the pathogenesis of hereditary angioedema.
@en
P2093
P2860
P2888
P304
P31
P356
10.1097/WOX.0B013E318216B7B2
P433
P478
P577
P5875
P6179
P698
P932